Targeted binding agents directed to alpha5beta1 and uses therefor
Details for Australian Patent Application No. 2009331529 (hide)
International Classifications
Event Publications
11 August 2011 Amendment Made
The nature of the amendment is: Amend the priority details to read 61/140,336 23 Dec 2008 US 2009333461 Sapphire Energy, Inc. The nature of the amendment is as shown in the statement(s) filed 01 Jul 2011
11 August 2011 PCT application entered the National Phase
PCT publication WO2010/072741 Priority application(s): WO2010/072741
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009331530-Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV
2009331528-Targeted binding agents directed to alpha5beta1 and uses thereof
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser